Designing multi-epitope vaccine against human cytomegalovirus integrating pan-genome and reverse vaccinology pipelines

Biologicals · Published 2024-07-13 · DOI 10.1016/j.biologicals.2024.101782

Authors being retrieved — see the publisher record. https://doi.org/10.1016/j.biologicals.2024.101782

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2024

Related articles

• Identification and computational analysis of B-cell epitopes on the hemagglutinin protein of the H3N2 influenza virus · Archives of Microbiology · 2026 · Cites or is cited by this article
• Optimization of a U937 cell-based reporter system to assess ADCC activity of ustekinumab versus trastuzumab · Biologicals · 2026 · Same journal
• Conference report WHO informal consultation on the draft WHO Guideline on the phasing out of animal tests for the quality control of biological products · Biologicals · 2025 · Same journal
• Status and progress in the development of rDNA-derived Tocilizumab and its biosimilars for treatment of rheumatoid arthritis · Biologicals · 2026 · Same journal
• Octanoic acid addition: a simple, affordable modification that overcomes lipid removal limitations of traditional antivenom production processes · Biologicals · 2025 · Same journal
• A comprehensive review of current diagnostic techniques for Monkeypox virus detection · Biologicals · 2025 · Same journal
• Regulatory workshop on standardisation of clinical procedures, endpoints and data robustness of human challenge studies – A stakeholder meeting report · Biologicals · 2025 · Same journal
• Functional characterization of the Clostridium perfringens quadruple point mutant epsilon toxin · Biologicals · 2025 · Same journal
• Integrating 3Rs approaches in WHO guidelines for the batch release testing of biologicals: Summary of NC3Rs final report to WHO Expert Committee for Biological Standardisation · Biologicals · 2024 · Same journal
• Report of the Ninth Asian National Control Laboratory Network meeting in 2024, with a focus on regional harmonization of regulatory systems to prepare for cross-border transfer of plasma · Biologicals · 2025 · Same journal